Reagents needed for the critical care medicine department for ongoing research.

Ended Awarded Last action

Contract number
75N90025F00004
Awardee
Awarding agency
Obligated
$24,970

Award facts

Contract value 100% obligated
$24,969.50 Current and potential, with all options
Completion date 100% complete
Current and potential, with all options
NAICS code
325413 In-Vitro Diagnostic Substance Manufacturing
PSC
6550 In Vitro Diagnostic Substances, Reagents, Test Kits And Sets
Set-aside
No set-aside
Competition
Not Competed under SAP · 1 offer Simplified Acquisition
Pricing
Firm Fixed Price
Place of performance
Pleasanton, CA 94588, USA

Award details come from SAM.gov/FPDS.

About this award

The NIH Clinical Center issued a BPA call to 10X Genomics, Inc. valued at $24,969.50 on May 28, 2025, for reagents needed by the Critical Care Medicine Department for ongoing research. Work is performed in Pleasanton, California, with an ultimate completion date of June 27, 2025. The call is issued on a firm fixed price basis with no set-aside.

Quick answers

Who was awarded contract 75N90025F00004?

75N90025F00004 was awarded to 10X Genomics, Inc. by NIH Clinical Center (National Institutes of Health) on May 28, 2025.

How much is contract 75N90025F00004 worth?

The government has obligated $24,970 on 75N90025F00004.

Is contract 75N90025F00004 an order under another contract?

Yes. 75N90025F00004 is a BPA call under 75N98022A00032, a blanket purchase agreement.

Was contract 75N90025F00004 competed?

The extent of competition for 75N90025F00004 was not competed under sap. The government received 1 offer.

On GovTribe

See this award's full record

  • Every transaction and funding action
  • The awardee's other awards and teaming partners
  • Similar awards and recompete opportunities
  • Ask GovTribe AI about this award